» Articles » PMID: 22870278

MicroRNA-34a Modulates MDM4 Expression Via a Target Site in the Open Reading Frame

Overview
Journal PLoS One
Date 2012 Aug 8
PMID 22870278
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MDM4, also called MDMX or HDMX in humans, is an important negative regulator of the p53 tumor suppressor. MDM4 is overexpressed in about 17% of all cancers and more frequently in some types, such as colon cancer or retinoblastoma. MDM4 is known to be post-translationally regulated by MDM2-mediated ubiquitination to decrease its protein levels in response to genotoxic stress, resulting in accumulation and activation of p53. At the transcriptional level, MDM4 gene regulation has been less clearly understood. We have reported that DNA damage triggers loss of MDM4 mRNA and a concurrent increase in p53 activity. These experiments attempt to determine a mechanism for down-regulation of MDM4 mRNA.

Methodology/principal Findings: Here we report that MDM4 mRNA is a target of hsa-mir-34a (miR-34a). MDM4 mRNA contains a lengthy 3' untranslated region; however, we find that it is a miR-34a site within the open reading frame (ORF) of exon 11 that is responsible for the repression. Overexpression of miR-34a, but not a mutant miR-34a, is sufficient to decrease MDM4 mRNA levels to an extent identical to those of known miR-34a target genes. Likewise, MDM4 protein levels are decreased by miR-34a overexpression. Inhibition of endogenous miR-34a increased expression of miR-34a target genes and MDM4. A portion of MDM4 exon 11 containing this 8mer-A1 miR-34a site fused to a luciferase reporter gene is sufficient to confer responsiveness, being inhibited by additional expression of exogenous mir-34a and activated by inhibition of miR-34a.

Conclusions/significance: These data establish a mechanism for the observed DNA damage-induced negative regulation of MDM4 and potentially provide a novel means to manipulate MDM4 expression without introducing DNA damage.

Citing Articles

Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.

Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.

PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.


Patient-matched tumours, plasma, and cell lines reveal tumour microenvironment- and cell culture-specific microRNAs.

Ludwig L, Vanderboon E, Treleaven H, Wood R, Schott C, Wood G Biol Open. 2024; 13(12).

PMID: 39714200 PMC: 11695573. DOI: 10.1242/bio.060483.


miR-34a is a tumor suppressor in zebrafish and its expression levels impact metabolism, hematopoiesis and DNA damage.

Prykhozhij S, Ban K, Brown Z, Kobar K, Wajnberg G, Fuller C PLoS Genet. 2024; 20(5):e1011290.

PMID: 38805544 PMC: 11166285. DOI: 10.1371/journal.pgen.1011290.


Quinazoline sulfonamide derivatives targeting MicroRNA-34a/MDM4/p53 apoptotic axis with radiosensitizing activity.

Soliman A, Kodous A, Al-Sherif D, Ghorab M Future Med Chem. 2024; 16(10):929-948.

PMID: 38661115 PMC: 11221547. DOI: 10.4155/fmc-2023-0342.


MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.

Fu J, Imani S, Wu M, Wu R Cancers (Basel). 2023; 15(19).

PMID: 37835417 PMC: 10571940. DOI: 10.3390/cancers15194723.


References
1.
Cummins J, Rago C, Kohli M, Kinzler K, Lengauer C, Vogelstein B . Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature. 2004; 428(6982):1 p following 486. DOI: 10.1038/nature02501. View

2.
Chen X . A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development. Science. 2003; 303(5666):2022-5. PMC: 5127708. DOI: 10.1126/science.1088060. View

3.
Markey M, Berberich S . Full-length hdmX transcripts decrease following genotoxic stress. Oncogene. 2008; 27(52):6657-66. PMC: 2610866. DOI: 10.1038/onc.2008.266. View

4.
Vaziri H, Dessain S, Ng Eaton E, Imai S, Frye R, Pandita T . hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001; 107(2):149-59. DOI: 10.1016/s0092-8674(01)00527-x. View

5.
Wynendaele J, Bohnke A, Leucci E, Jensby Nielsen S, Lambertz I, Hammer S . An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res. 2010; 70(23):9641-9. DOI: 10.1158/0008-5472.CAN-10-0527. View